Advancing mRNA production through platform and continuous process development

The field of mRNA therapeutics is undergoing transformative growth, driven by innovations in both process development and automation. However, with this progress comes a number of complex challenges. David McCall, Senior Editor, BioInsights, speaks with Zoltán Kis, Senior Lecturer at The University of Sheffield, about platform technologies, continuous process development, advanced automation, and the future of mRNA manufacturing.

Please enter your email to access content Read now